FDA authorizes test to identify and differentiate SARS-CoV-2 strains

Advertisements

FDA authorizes test to identify and differentiate SARS-CoV-2 strains
kpage_drupal
Jun 15, 2022

The Food and Drug Administration Friday authorized the first COVID-19 test to identify and differentiate certain SARS-CoV-2 lineages in respiratory samples that test positive for the virus. The emergency use authorization (allows certain laboratories certified under the Clinical Laboratory Improvement Amendments to perform the Labcorp next generation sequencing test.
 

Headline
Advertisements
Shopping Cart
Generated by Feedzy
error: Content is protected !!
Share via
Copy link
Powered by Social Snap